Page last updated: 2024-09-04

triphenylselenonium chloride and Experimental Mammary Neoplasms

triphenylselenonium chloride has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ganther, HE; Ip, C; Thompson, HJ1

Other Studies

1 other study(ies) available for triphenylselenonium chloride and Experimental Mammary Neoplasms

ArticleYear
Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2000, Volume: 9, Issue:1

    Topics: Animals; Anticarcinogenic Agents; Antimetabolites; Antineoplastic Agents; Biomarkers; Bromodeoxyuridine; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Transformation, Neoplastic; Chemoprevention; Coloring Agents; Cyclin D; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Cysteine; Enzyme Inhibitors; Female; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Microtubule-Associated Proteins; Organoselenium Compounds; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Selenocysteine; Tumor Suppressor Proteins

2000